-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Roivant Sciences, Raises Price Target to $55

Benzinga·09/09/2026 14:38:57
Listen to the news
TD Cowen analyst Yaron Werber maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $50 to $55.